ICON CAPSULES 100mg
ICON CAPSULES (Itraconzole capsules)
These capsules contain Itraconazole, an azole antifungal agent, used for treating various fungal infections
Icon is prescribed for conditions like vulvovaginal candidiasis, blastomycosis, derma to phytoses, oropharyngeal candidiasis, and onychomycosis caused by dermatophytes and/or yeasts
There is a caution against administering Itraconazole Capsules in patients with evidence of congestive heart failure (CHF), as negative inotropic effects were observed during intravenous administration
The recommended dosage varies for different indications, ranging from 100 mg once daily to 200 mg twice daily, depending on the severity and type of fungal infection
Itraconazole has potential drug interactions, particularly with CYP3A4 inhibitors, and caution is advised in patients with hepatic dysfunction. Additionally, it should not be used during pregnancy, except in life-threatening cases. Regular monitoring and adjustments are necessary for patients
VORIF TABLETS 200mg
VORIF TABLETS (Voriconazole tablets)
VORIF, containing Voriconazole, demonstrates potent antifungal activity by inhibiting fungal cytochrome P-450 enzymes crucial for ergosterol biosynthesis.
Indicated for invasive aspergillosis, esophageal candidiasis, candidemia, and serious fungal infections, VORIF addresses a spectrum of fungal challenges in both adults and children.
The dosage regimen, including a loading dose for the first 24 hours, ensures rapid achievement of therapeutic plasma concentrations. Subsequent maintenance doses vary based on patient weight.
While generally well-tolerated, users should be mindful of potential adverse reactions, including hypokalemia, visual changes, and, rarely, serious events like pancreatitis or Stevens-Johnson syndrome.
VORIF is contraindicated in cases of hypersensitivity to voriconazole components and when co administered with specific drugs like rifampin, ritonavir, and carbamazepine due to potential interactions
VORIF TABLETS 50mg
VORIF TABLETS (Voriconazole tablets)
VORIF, containing Voriconazole, demonstrates potent antifungal activity by inhibiting fungal cytochrome P-450 enzymes crucial for ergosterol biosynthesis.
Indicated for invasive aspergillosis, esophageal candidiasis, candidemia, and serious fungal infections, VORIF addresses a spectrum of fungal challenges in both adults and children.
The dosage regimen, including a loading dose for the first 24 hours, ensures rapid achievement of therapeutic plasma concentrations. Subsequent maintenance doses vary based on patient weight.
While generally well-tolerated, users should be mindful of potential adverse reactions, including hypokalemia, visual changes, and, rarely, serious events like pancreatitis or Stevens-Johnson syndrome.
VORIF is contraindicated in cases of hypersensitivity to voriconazole components and when co administered with specific drugs like rifampin, ritonavir, and carbamazepine due to potential interactions
AZOBAR TABLETS 500mg
AZOBAR TABLETS (Azithromycin tablets)
Azobar, featuring Azithromycin, offers a potent defense against a variety of bacterial infections, ranging from respiratory issues to skin infections
Tailored for both adults and children, Azobar addresses conditions like sinusitis, bronchitis, pneumonia, and skin infections, making it a versatile solution for various age groups
While effective, Azobar requires caution in specific cases, such as severe illness, cystic fibrosis, and nosocomial infections, ensuring optimal and safe usage
Physicians should closely monitor patients for potential adverse effects, including gastrointestinal symptoms, allergic reactions, and hepatotoxicity, optimizing the overall safety profile
Proper storage below 30°C and strict adherence to prescription guidelines ensure Azobar's integrity, emphasizing its commitment to both efficacy and patient safety
AZOBAR TABLETS 250mg
AZOBAR TABLETS (Azithromycin tablets)
Azobar, featuring Azithromycin, offers a potent defense against a variety of bacterial infections, ranging from respiratory issues to skin infections
Tailored for both adults and children, Azobar addresses conditions like sinusitis, bronchitis, pneumonia, and skin infections, making it a versatile solution for various age groups
While effective, Azobar requires caution in specific cases, such as severe illness, cystic fibrosis, and nosocomial infections, ensuring optimal and safe usage
Physicians should closely monitor patients for potential adverse effects, including gastrointestinal symptoms, allergic reactions, and hepatotoxicity, optimizing the overall safety profile
Proper storage below 30°C and strict adherence to prescription guidelines ensure Azobar's integrity, emphasizing its commitment to both efficacy and patient safety